49 results on '"Cristofori, Fernanda"'
Search Results
2. Novel Bacteroides Vulgatus strain protects against gluten-induced break of human celiac gut epithelial homeostasis: a pre-clinical proof-of-concept study
- Author
-
Tran, Tina, Senger, Stefania, Baldassarre, Mariella, Brosnan, Rachel A., Cristofori, Fernanda, Crocco, Marco, De Santis, Stefania, Elli, Luca, Faherty, Christina S., Francavilla, Ruggero, Goodchild-Michelman, Isabella, Kenyon, Victoria A., Leonard, Maureen M., Lima, Rosiane S., Malerba, Federica, Montuori, Monica, Morelli, Annalisa, Norsa, Lorenzo, Passaro, Tiziana, Piemontese, Pasqua, Reed, James C., Sansotta, Naire, Valitutti, Francesco, Zomorrodi, Ali R., and Fasano, Alessio
- Published
- 2024
- Full Text
- View/download PDF
3. Functional Abdominal Pain Disorders and Constipation in Children on Gluten-Free Diet
- Author
-
Cristofori, Fernanda, Tripaldi, Mariaelena, Lorusso, Giusi, Indrio, Flavia, Rutigliano, Vincenzo, Piscitelli, Domenico, Castellaneta, Stefania, Bentivoglio, Vincenzo, and Francavilla, Ruggiero
- Published
- 2021
- Full Text
- View/download PDF
4. Celiac Disease: The Importance of Studying the Duodenal Mucosa-Associated Microbiota.
- Author
-
Annunziato, Alessandro, Vacca, Mirco, Cristofori, Fernanda, Dargenio, Vanessa Nadia, Celano, Giuseppe, Francavilla, Ruggiero, and De Angelis, Maria
- Abstract
There is increasing evidence indicating that changes in both the composition and functionality of the intestinal microbiome are closely associated with the development of several chronic inflammatory diseases, with celiac disease (CeD) being particularly noteworthy. Thanks to the advent of culture-independent methodologies, the ability to identify and quantify the diverse microbial communities residing within the human body has been significantly improved. However, in the context of CeD, a notable challenge lies in characterizing the specific microbiota present on the mucosal surfaces of the intestine, rather than relying solely on fecal samples, which may not fully represent the relevant microbial populations. Currently, our comprehension of the composition and functional importance of mucosa-associated microbiota (MAM) in CeD remains an ongoing field of research because the limited number of available studies have reported few and sometimes contradictory results. MAM plays a crucial role in the development and progression of CeD, potentially acting as both a trigger and modulator of the immune response within the intestinal mucosa, given its proximity to the epithelial cells and direct interaction. According to this background, this review aims to consolidate the existing literature specifically focused on MAM in CeD. By elucidating the complex interplay between the host immune system and the gut microbiota, we aim to pave the way for new interventions based on novel therapeutic targets and diagnostic biomarkers for MAM in CeD. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. Mucoadhesive Budesonide Solution for the Treatment of Pediatric Eosinophilic Esophagitis.
- Author
-
Spennacchio, Antonio, Lopalco, Antonio, Racaniello, Giuseppe Francesco, Cutrignelli, Annalisa, la Forgia, Flavia Maria, Fontana, Sergio, Cristofori, Fernanda, Francavilla, Ruggiero, Lopedota, Angela Assunta, and Denora, Nunzio
- Subjects
EOSINOPHILIC esophagitis ,PEDIATRIC therapy ,BUDESONIDE ,CHILD patients ,THERAPEUTICS ,PHYSICIANS ,SUMATRIPTAN - Abstract
Eosinophilic Esophagitis is an antigen-mediated inflammatory disease characterized by thickening of the esophageal wall, leading to dysphagia, vomiting, reflux, and abdominal pain. This disease can be treated with a therapeutic approach ranging from diet to pharmacological therapy. Jorveza
® (budesonide) and Dupixent® (dupilumab) are treatments for Eosinophilic Esophagitis approved by the European Medicines Agency in adults but not in children. Budesonide-based extemporaneous oral liquid suspensions could be prepared for pediatric use. The main limit of this formulation is that budesonide needs a longer residence time on the esophageal mucosa to solubilize and diffuse in it to exert its local anti-inflammatory effect. Herein, we propose the development of an extemporaneous mucoadhesive oral budesonide solution for the pediatric population. A liquid vehicle containing hydroxypropyl-beta-cyclodextrin as a complexing agent and carboxymethylcellulose sodium as a mucoadhesive excipient was used to prepare budesonide-based formulations. A stable solution at a concentration of 0.7 mg/mL was successfully prepared and characterized. The formulation showed rheological and mucoadhesive properties suitable for an Eosinophilic Esophagitis local prolonged treatment. In this way, pharmacists can prepare stable budesonide-based mucoadhesive solutions, providing both patients and physicians with a new therapeutic option for Eosinophilic Esophagitis pediatric treatment. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
6. Esophageal pH-impedance monitoring in children: position paper on indications, methodology and interpretation by the SIGENP working group
- Author
-
Quitadamo, Paolo, Tambucci, Renato, Mancini, Valentina, Cristofori, Fernanda, Baldassarre, Mariella, Pensabene, Licia, Francavilla, Ruggiero, Di Nardo, Giovanni, Caldaro, Tamara, Rossi, Paolo, Mallardo, Saverio, Maggiora, Elena, Staiano, Annamaria, Cresi, Francesco, Salvatore, Silvia, and Borrelli, Osvaldo
- Published
- 2019
- Full Text
- View/download PDF
7. Intervention for Dysbiosis in Children Born by C-Section
- Author
-
Francavilla, Ruggiero, Cristofori, Fernanda, Tripaldi, Maria Elena, and Indrio, Flavia
- Published
- 2018
8. Long-term outcomes of Heller’s myotomy and balloon dilatation in childhood achalasia
- Author
-
Saliakellis, Efstratios, Thapar, Nikhil, Roebuck, Derek, Cristofori, Fernanda, Cross, Kate, Kiely, Edward, Curry, Joseph, Lindley, Keith, and Borrelli, Osvaldo
- Published
- 2017
- Full Text
- View/download PDF
9. Prevalence and detection rate of celiac disease in Italy: Results of a SIGENP multicenter screening in school-age children.
- Author
-
Lionetti, Elena, Pjetraj, Dorina, Gatti, Simona, Catassi, Giulia, Bellantoni, Antonella, Boffardi, Massimo, Cananzi, Mara, Cinquetti, Mauro, Francavilla, Ruggiero, Malamisura, Basilio, Montuori, Monica, Zuccotti, Gianvincenzo, Cristofori, Fernanda, Gaio, Paola, Passaro, Tiziana, Penagini, Francesca, Testa, Alessandra, Trovato, Chiara Maria, and Catassi, Carlo
- Abstract
Celiac disease is a common lifelong disorder. Recent studies indicate that the number of clinically detected cases has increased over the last decades, however little is known about changes in the prevalence and the detection rate of celiac disease. To evaluate the current prevalence and detection rate of celiac disease in Italy by a multicenter, mass screening study on a large sample of school-age children. children aged 5–11 years were screened at school by HLA-DQ2 and -DQ8 determination on a drop of blood in six Italian cities; total serum IgA and IgA anti-transglutaminase were determined in children showing HLA-DQ2 and/or -DQ8 positivity. Diagnosis of celiac disease was confirmed according to the European guidelines. 5994 children were eligible, 4438 participated and 1873 showed predisposing haplotypes (42.2%, 95% CI=40.7–43.7). The overall prevalence of celiac disease was 1.65% (95% CI, 1.34%–2.01%). Only 40% of celiac children had been diagnosed prior to the school screening. Symptoms evoking celiac disease were as common in celiac children as in controls. In this multicenter study the prevalence of celiac disease in school-age Italian children was one of the highest in the world. Determination of HLA predisposing genotypes is an easy and fast first-level screening test for celiac disease. Without a mass screening strategy, 60% of celiac patients remain currently undiagnosed in Italy. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
10. Gut Immunobiosis and Biomodulators.
- Author
-
Miniello, Vito Leonardo, Miniello, Andrea, Ficele, Laura, Skublewska-D'Elia, Aleksandra, Dargenio, Vanessa Nadia, Cristofori, Fernanda, and Francavilla, Ruggiero
- Abstract
The human gastrointestinal (GI) tract hosts complex and dynamic populations of microorganisms (gut microbiota) in advantageous symbiosis with the host organism through sophisticated molecular cross-talk. The balance and diversification within microbial communities (eubiosis) are crucial for the immune and metabolic homeostasis of the host, as well as for inhibiting pathogen penetration. In contrast, compositional dysregulation of the microbiota (dysbiosis) is blamed for the determinism of numerous diseases. Although further advances in the so-called 'omics' disciplines are needed, dietary manipulation of the gut microbial ecosystem through biomodulators (prebiotics, probiotics, symbionts, and postbiotics) represents an intriguing target to stabilize and/or restore eubiosis. Recently, new approaches have been developed for the production of infant formulas supplemented with prebiotics (human milk oligosaccharides [HMOs], galacto-oligosaccharides [GOS], fructo-oligosaccharides [FOS]), probiotics, and postbiotics to obtain formulas that are nutritionally and biologically equivalent to human milk (closer to the reference). [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
11. Intestinal Barrier Dysfunction and Microbiota–Gut–Brain Axis: Possible Implications in the Pathogenesis and Treatment of Autism Spectrum Disorder.
- Author
-
Dargenio, Vanessa Nadia, Dargenio, Costantino, Castellaneta, Stefania, De Giacomo, Andrea, Laguardia, Marianna, Schettini, Federico, Francavilla, Ruggiero, and Cristofori, Fernanda
- Abstract
Autism spectrum disorder (ASD) is a complex neurodevelopmental disorder with multifactorial etiology, characterized by impairment in two main functional areas: (1) communication and social interactions, and (2) skills, interests and activities. ASD patients often suffer from gastrointestinal symptoms associated with dysbiotic states and a "leaky gut." A key role in the pathogenesis of ASD has been attributed to the gut microbiota, as it influences central nervous system development and neuropsychological and gastrointestinal homeostasis through the microbiota–gut–brain axis. A state of dysbiosis with a reduction in the Bacteroidetes/Firmicutes ratio and Bacteroidetes level and other imbalances is common in ASD. In recent decades, many authors have tried to study and identify the microbial signature of ASD through in vivo and ex vivo studies. In this regard, the advent of metabolomics has also been of great help. Based on these data, several therapeutic strategies, primarily the use of probiotics, are investigated to improve the symptoms of ASD through the modulation of the microbiota. However, although the results are promising, the heterogeneity of the studies precludes concrete evidence. The aim of this review is to explore the role of intestinal barrier dysfunction, the gut–brain axis and microbiota alterations in ASD and the possible role of probiotic supplementation in these patients. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
12. Risk of obesity during a gluten-free diet in pediatric and adult patients with celiac disease: a systematic review with meta-analysis.
- Author
-
Barone, Michele, Iannone, Andrea, Cristofori, Fernanda, Dargenio, Vanessa Nadia, Indrio, Flavia, Verduci, Elvira, Leo, Alfredo Di, and Francavilla, Ruggiero
- Subjects
CELIAC disease diagnosis ,RISK of childhood obesity ,ONLINE information services ,EXPERIMENTAL design ,META-analysis ,CONFIDENCE intervals ,BODY weight ,CHILDHOOD obesity ,SYSTEMATIC reviews ,AGE distribution ,CELIAC disease ,LEANNESS ,DESCRIPTIVE statistics ,DISEASE prevalence ,BODY mass index ,MEDLINE ,STATISTICAL models ,DATA analysis software ,GLUTEN-free diet ,CHILDREN ,ADULTS ,ADOLESCENCE - Abstract
Context Obesity is a significant risk factor for many pathological conditions. Whether a gluten-free diet (GFD) is a risk factor for overweight or obesity remains controversial. Objective The primary aim of this study was to assess the prevalence of body mass index (BMI) categories at disease presentation and the variation in BMI category from underweight/normal to overweight/obese and vice versa during a GFD. Data Sources PubMed, Scopus, and Web of Science databases were searched through February 2021 for retrospective, cross-sectional, and prospective studies reporting BMI categories at disease diagnosis and during a GFD. Data Extraction Data were extracted by 2 reviewers independently. Disagreements were resolved by consensus; a third reviewer was consulted, if necessary. Risk of bias was assessed with the Cochrane ROBINS-I tool. Data Analysis Subgroup analysis based on age (pediatric/adult patients), study design (prospective, cross-sectional, retrospective), and duration of GFD was performed.. Forty-five studies were selected (7959 patients with celiac disease and 20 524 healthy controls). The mean BMI of celiac patients at presentation was significantly lower than that of controls (P < 0.001). During a GFD, the mean BMI increased significantly (mean difference = 1.14 kg/m
2 [95%CI, 0.68–1.60 kg/m2 ]; I2 = 82.8%; P < 0.001), but only 9% of patients (95%CI, 7%–12%; I2 = 80.0%) changed from the underweight/normal BMI category to the overweight/obese category, while 20% (95%CI, 11%–29%; I2 = 85.8%) moved into a lower BMI category. Conclusion Most celiac patients had a normal BMI at presentation, although the mean BMI was significantly lower than that of controls. A GFD does not increase the risk of becoming overweight/obese, especially in children. The quality of several studies was suboptimal, with moderate or high overall risk of bias and heterogeneity. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
13. Gluten Sensitivity in Pediatrics: A Clinical Conundrum
- Author
-
Cristofori, Fernanda, Arezzo, Francesca, Gentile, Antonia, and Francavilla, Ruggiero
- Published
- 2014
- Full Text
- View/download PDF
14. Probiotics and gastrointestinal diseases.
- Author
-
DARGENIO, Vanessa N., CASTELLANETA, Stefania, PANICO, Serena, PAPAGNI, Maria E., DARGENIO, Costantino, SCHETTINI, Federico, FRANCAVILLA, Ruggiero, and CRISTOFORI, Fernanda
- Published
- 2022
- Full Text
- View/download PDF
15. High Rate of Spontaneous Normalization of Celiac Serology in a Cohort of 446 Children With Type 1 Diabetes: A Prospective Study
- Author
-
Castellaneta, Stefania, Piccinno, Elvira, Oliva, Marica, Cristofori, Fernanda, Vendemiale, Marcella, Ortolani, Federica, Papadia, Francesco, Catassi, Carlo, Cavallo, Luciano, and Francavilla, Ruggiero
- Published
- 2015
- Full Text
- View/download PDF
16. Nutritional Assessment of Baby Food Available in Italy.
- Author
-
Antignani, Angelo, Francavilla, Ruggiero, Vania, Andrea, Leonardi, Lucia, Di Mauro, Cristina, Tezza, Giovanna, Cristofori, Fernanda, Dargenio, Vanessa Nadia, Scotese, Immacolata, Palma, Filomena, and Caroli, Margherita
- Abstract
Adequate complementary feeding practices are important for short- and long-term child health. In industrialized countries, the formulation of several commercial baby foods (CBFs) and an increase in their consumption has been noticed. Aim: To update and analyze the nutritional composition of CBFs available in the Italian market. Methods: Data collection carried out in two steps (July 2018–January 2019) and updated in May–September 2021. The information on CBFs was taken from the websites of the major CBF producers available in Italy. The collected information were: Suggested initial and final age of consumption; Ingredients; Energy value; Macronutrients (protein, lipids, and carbohydrates); Fiber; Micronutrients (sodium, iron, and calcium); Presence of salt and added sugars, flavorings, and other additives. Results: Time-space for which CBFs are recommended starts too early and ends too late; protein content is adequate and even too high in some food; Amount of fats and their quality must be improved, keeping the intake of saturated fats low; Sugar content is too high in too many CBFs and salt is unnecessarily present in some of them. Finally, the texture of too many products is purée, and its use is recommended for too long, hindering the development of infants' chewing abilities. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
17. Twelve Months with COVID-19: What Gastroenterologists Need to Know.
- Author
-
Concas, Giulia, Barone, Michele, Francavilla, Ruggiero, Cristofori, Fernanda, Dargenio, Vanessa Nadia, Giorgio, Rossella, Dargenio, Costantino, Fanos, Vassilios, and Marcialis, Maria Antonietta
- Abstract
Corona virus disease-19 (COVID-19) is the latest global pandemic. COVID-19 is mainly transmitted through respiratory droplets and, apart from respiratory symptoms, patients often present with gastrointestinal symptoms and liver involvement. Given the high percentage of COVID-19 patients that present with gastrointestinal symptoms (GIS), in this review, we report a practical up-to-date reference for the physician in their clinical practice with patients affected by chronic gastrointestinal (GI) diseases (inflammatory bowel disease, coeliac disease, chronic liver disease) at the time of COVID-19. First, we summarised data on the origin and pathogenetic mechanism of SARS-CoV-2. Then, we performed a literature search up to December 2020 examining clinical manifestations of GI involvement. Next, we illustrated and summarised the most recent guidelines on how to adhere to GI procedures (endoscopy, liver biopsy, faecal transplantation), maintaining social distance and how to deal with immunosuppressive treatment. Finally, we focussed on some special conditions such as faecal–oral transmission and gut microbiota. The rapid accumulation of information relating to this condition makes it particularly essential to revise the literature to take account of the most recent publications for medical consultation and patient care. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
18. Clinical, Serologic, and Histologic Features of Gluten Sensitivity in Children
- Author
-
Francavilla, Ruggiero, Cristofori, Fernanda, Castellaneta, Stefania, Polloni, Carlo, Albano, Veronica, Dellatte, Stefania, Indrio, Flavia, Cavallo, Luciano, and Catassi, Carlo
- Published
- 2014
- Full Text
- View/download PDF
19. Retrospective Study on Breastfeeding Practices by SARS-COV-2 Positive Mothers in a High Risk Area for Coronavirus Infection.
- Author
-
Indrio, Flavia, Mantovani, Massimo Pettoello, Salatto, Alessia, Rinaldi, Matteo, Dargenio, Vanessa Nadia, Cristofori, Fernanda, Marchese, Flavia, Bianchi, Francesco Paolo, Nappi, Luigi, and Maffei, Gianfranco
- Subjects
MATERNAL health services ,COVID-19 ,PSYCHOLOGY of mothers ,RETROSPECTIVE studies ,MOTHER-infant relationship ,BREASTFEEDING ,HAND washing ,VERTICAL transmission (Communicable diseases) - Abstract
Background: During the pandemic of SARS-Cov-2, among other clinical and public health issues, a major concern raised by SARS-CoV-2 is the possibility of transmission of the infection from mother to child in the perinatal period. This has placed a question mark on the safety of breastfeeding, with ambiguity on the joint management of SARS-CoV-2 positive or suspected mothers and their children. It was aimed to evaluate breastfeeding rates for newborns of asymptomatic SARS-CoV-2 positive mothers who were temporarily separated from their babies at birth, compared to those who were not separated. Results: Babies who were not isolated from their mothers at delivery were significantly more likely to be breastfed and were at no higher risk of infection with SARS-CoV-2. Conclusion: Following the World Health Organization (WHO) recommendations and strict hand and mask hygiene measures, breastfeeding practices can be established and maintained through rooming-in, thus promoting the mother-child bond without compromising the safety of the newborn. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
20. Limosilactobacillus reuteri Strains as Adjuvants in the Management of Helicobacter pylori Infection.
- Author
-
Dargenio, Costantino, Dargenio, Vanessa Nadia, Bizzoco, Francesca, Indrio, Flavia, Francavilla, Ruggiero, and Cristofori, Fernanda
- Subjects
LACTIC acid bacteria ,HELICOBACTER pylori infections ,GASTRIC diseases ,GUT microbiome ,LYMPHOMAS - Abstract
Helicobacter pylori (HP) is a Gram-negative bacterium which finds its suitable habitat in the stomach. The infection affects about half of the global population with high variability in prevalence among regions and for age. HP is the main causative agent of chronic active gastritis, peptic and duodenal ulcers, and may be the primary cause of gastric cancer or MALT lymphoma. Due to the high rate of failure of eradication therapy in various countries and the increase in antibiotic resistance reported in the literature, there is an ever wider need to seek alternative therapeutic treatments. Probiotics seem to be a promising solution. In particular, the Limosilactobacillus reuteri (L. reuteri) species is a Gram-positive bacterium and is commonly found in the microbiota of mammals. L. reuteri is able to survive the gastric acid environment and bile and to colonize the gastric mucosa. This species is able to inhibit the growth of several pathogenic bacteria through different mechanisms, keeping the homeostasis of the microbiota. In particular, it is able to secrete reuterin and reutericycline, substances that exhibit antimicrobial properties, among other molecules. Through the secretion of these and the formation of the biofilm, it has been found to strongly inhibit the growth of HP and, at higher concentrations, to kill it. Moreover, it reduces the expression of HP virulence factors. In clinical trials, L. reuteri has been shown to decrease HP load when used as a single treatment, but has not achieved statistical significance in curing infected patients. As an adjuvant of standard regimens with antibiotics and pump inhibitors, L. reuteri can be used not only to improve cure rates, but especially to decrease gastrointestinal symptoms, which are a common cause of lack of compliance and interruption of therapy, leading to new antibiotic resistance. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
21. Diagnostic Delay of Celiac Disease in Childhood.
- Author
-
Bianchi, Paola Ilaria, Lenti, Marco Vincenzo, Petrucci, Clarissa, Gambini, Giulia, Aronico, Nicola, Varallo, Matteo, Rossi, Carlo Maria, Pozzi, Elena, Groppali, Elena, Siccardo, Francesca, Franchino, Giulia, Zuccotti, Gian Vincenzo, Di Leo, Grazia, Zanchi, Chiara, Cristofori, Fernanda, Francavilla, Ruggiero, Aloi, Marina, Gagliostro, Giulia, Montuori, Monica, and Romaggioli, Sara
- Published
- 2024
- Full Text
- View/download PDF
22. Anti-Inflammatory and Immunomodulatory Effects of Probiotics in Gut Inflammation: A Door to the Body.
- Author
-
Cristofori, Fernanda, Dargenio, Vanessa Nadia, Dargenio, Costantino, Miniello, Vito Leonardo, Barone, Michele, and Francavilla, Ruggiero
- Subjects
PROBIOTICS ,GUT microbiome ,CELL receptors ,BODY mass index ,TOLL-like receptors - Abstract
Hosting millions of microorganisms, the digestive tract is the primary and most important part of bacterial colonization. On one side, in cases of opportunistic invasion, the abundant bacterial population inside intestinal tissues may face potential health problems such as inflammation and infections. Therefore, the immune system has evolved to sustain the host–microbiota symbiotic relationship. On the other hand, to maintain host immune homeostasis, the intestinal microflora often exerts an immunoregulatory function that cannot be ignored. A field of great interest is the association of either microbiota or probiotics with the immune system concerning clinical uses. This microbial community regulates some of the host's metabolic and physiological functions and drives early-life immune system maturation, contributing to their homeostasis throughout life. Changes in gut microbiota can occur through modification in function, composition (dysbiosis), or microbiota–host interplays. Studies on animals and humans show that probiotics can have a pivotal effect on the modulation of immune and inflammatory mechanisms; however, the precise mechanisms have not yet been well defined. Diet, age, BMI (body mass index), medications, and stress may confound the benefits of probiotic intake. In addition to host gut functions (permeability and physiology), all these agents have profound implications for the gut microbiome composition. The use of probiotics could improve the gut microbial population, increase mucus-secretion, and prevent the destruction of tight junction proteins by decreasing the number of lipopolysaccharides (LPSs). When LPS binds endothelial cells to toll-like receptors (TLR 2, 4), dendritic cells and macrophage cells are activated, and inflammatory markers are increased. Furthermore, a decrease in gut dysbiosis and intestinal leakage after probiotic therapy may minimize the development of inflammatory biomarkers and blunt unnecessary activation of the immune system. In turn, probiotics improve the differentiation of T-cells against Th2 and development of Th2 cytokines such as IL-4 and IL-10. The present narrative review explores the interactions between gut microflora/probiotics and the immune system starting from the general perspective of a biological plausibility to get to the in vitro and in vivo demonstrations of a probiotic-based approach up to the possible uses for novel therapeutic strategies. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
23. Bacterial-Based Strategies to Hydrolyze Gluten Peptides and Protect Intestinal Mucosa.
- Author
-
Cristofori, Fernanda, Francavilla, Ruggiero, Capobianco, Daniela, Dargenio, Vanessa Nadia, Filardo, Simone, and Mastromarino, Paola
- Subjects
GLIADINS ,INTESTINAL mucosa ,PEPTIDES ,GLUTEN ,CELIAC disease ,LACTIC acid bacteria - Abstract
Gluten is a mixture of proteins highly resistant to hydrolysis, resulting in the emergence of toxic peptides responsible for gluten-related disorders. Currently, a gluten-free diet (GFD) is the unique proven therapy for celiac disease (CD). Several research groups and pharmaceutical companies are developing new nondietetic therapeutic strategies for CD. Probiotics are viable microorganisms thought to have a healthy effect on the host. The proteolytic mechanism of lactic acid bacteria comprises an extracellular serine protease, di- and oligopeptide-specific transport systems, and several intracellular peptidases that might affect gluten degradation. Therefore, probiotic supplementation is an attractive therapy because of its possible anti-inflammatory and immunomodulatory properties. Several studies have been performed to assess the effectiveness of various specific probiotic strains, showing positive effects on immune-modulation (inhibition of pro-inflammatory cytokine TNF-α) restoring gut microbiota and decrease of immunogenic peptides. The present review aims to summarize the current knowledge on the ability of probiotic strain (single or mixtures) to digest gliadin peptides in vitro and to modulate the inflammatory response in the gut. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
24. Multichannel Intraluminal Impedance and pH Monitoring: A Step Towards Pediatric Reference Values.
- Author
-
Cresi, Francesco, Cester, Elena Andrea, Salvatore, Silvia, De Rose, Domenico Umberto, Ripepi, Antonio, Magistà, Anna Maria, Fontana, Claudia, Maggiora, Elena, Coscia, Alessandra, Francavilla, Ruggiero, and Cristofori, Fernanda
- Subjects
REFERENCE values ,NEWBORN infants ,GASTROESOPHAGEAL reflux ,DIAGNOSIS ,SYMPTOMS - Abstract
Background/Aims Combined multichannel intraluminal impedance and pH monitoring (MII/pH) is considered the most accurate test to detect gastroesophageal reflux (GER), however lacking reference values. We aim to determine reference values for the pediatric population and to correlate these values with age and postprandial/fasting period. Methods We evaluated MII/pH traces from patients (newborns, infants, and children) admitted to 3 Italian hospitals and who underwent MII/pH for suspected GER disease. Patients with MII/pH traces that showed significant symptom-reflux associations and/or a pathological reflux index (> 6% for newborns and infants, > 3% for children) were excluded. Traces were analysed in their entirety, and in the postprandial period (first hour after a meal) and the fasting period (the following hours before the next meal) separately. Results A total of 195 patients (46 newborns, 83 infants, and 66 children) were included. Age positively correlated with frequency of acidic GER events (r = 0.37, P < 0.05) and negatively associated with weakly acidic GER events (r = 0.46, P < 0.05). Conclusions This study describes the distribution of MII/pH values in a pediatric population with normally acidic GER exposure and no significant association between GER events and symptoms. These MII/pH values may be used as reference values in clinical practice for a corrected GER disease diagnosis in the pediatric population. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
25. Advances in understanding the potential therapeutic applications of gut microbiota and probiotic mediated therapies in celiac disease.
- Author
-
Francavilla, Ruggiero, Cristofori, Fernanda, Vacca, Mirco, Barone, Michele, and De Angelis, Maria
- Subjects
CELIAC disease ,GUT microbiome ,GLUTEN-free diet ,GLUTEN allergenicity ,PATHOLOGY ,IRRITABLE colon - Abstract
Celiac Disease (CD) is an autoimmune enteropathy caused by exposure to gluten in genetically predisposed people. While gluten is the main driving force in CD, evidence has shown that microbiota might be involved in the pathogenesis, development, and clinical presentation of CD. Microbiota manipulation may modify its functional capacity and may be crucial for setting-up potential preventive or therapeutic application. Moreover, probiotics are an excellent source of endopeptidases for digesting gluten. In this narrative review we illustrate all the recent scientific discoveries in this field including CD pathogenetic mechanism where gut microbiota might be involved and possible use of probiotics in CD prevention and treatment. In the future, probiotics could be used as an add-on medication for strengthening/facilitating the gluten-free diet (GFD) and improving symptoms; the prospect of using it for therapeutic purposes is to be sought in a more distant future. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
26. Precision microbial intervention improves social behavior but not autism severity: A pilot double-blind randomized placebo-controlled trial.
- Author
-
Mazzone, Luigi, Dooling, Sean W., Volpe, Elisabetta, Uljarević, Mirko, Waters, Jillian L., Sabatini, Andrea, Arturi, Lucrezia, Abate, Roberta, Riccioni, Assia, Siracusano, Martina, Pereira, Marcela, Engstrand, Lars, Cristofori, Fernanda, Adduce, Domenico, Francavilla, Ruggiero, Costa-Mattioli, Mauro, and Hardan, Antonio Y.
- Abstract
Autism spectrum disorder (ASD) is characterized by the presence of restricted/repetitive behaviors and social communication deficits. Because effective treatments for ASD remain elusive, novel therapeutic strategies are necessary. Preclinical studies show that L. reuteri selectively reversed social deficits in several models for ASD. Here, in a double-blind, randomized, placebo-controlled trial, we tested the effect of L. reuteri (a product containing a combination of strains ATCC-PTA-6475 and DSM-17938) in children with ASD. The treatment does not alter overall autism severity, restricted/repetitive behaviors, the microbiome composition, or the immune profile. However, L. reuteri combination yields significant improvements in social functioning that generalized across different measures. Interestingly, ATCC-PTA-6475, but not the parental strain of DSM-17938, reverses the social deficits in a preclinical mouse model for ASD. Collectively, our findings show that L. reuteri enhances social behavior in children with ASD, thereby warranting larger trials in which strain-specific effects should also be investigated. [Display omitted] • L. reuteri (6475 + 17938) improves social functioning in children with autism • L. reuteri does not improve overall autism severity or repetitive behaviors • L. reuteri does not significantly alter microbiome composition or immune profile • Only the 6475 strain reverses the social deficits in a mouse model for autism L. reuteri treatment (ATCC-PTA-6475 + DSM-17938) improves social functioning in children with autism, but not other symptoms. Interestingly, the ATCC-PTA-6475 strain, but not the parental strain of DSM-17938, improves social behavior in mice. The findings warrant larger trials in which the effect of specific strains is also tested. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
27. Clinical and Microbiological Effect of a Multispecies Probiotic Supplementation in Celiac Patients With Persistent IBS-type Symptoms: A Randomized, Double-Blind, Placebo-controlled, Multicenter Trial.
- Author
-
Francavilla, Ruggiero, Piccolo, Maria, Francavilla, Antonio, Polimeno, Lorenzo, Semeraro, Francesco, Cristofori, Fernanda, Castellaneta, Stefania, Barone, Michele, Indrio, Flavia, Gobbetti, Marco, and De Angelis, Maria
- Published
- 2019
- Full Text
- View/download PDF
28. An Unexpected Guest in a Patient With Ulcerative Colitis.
- Author
-
Dargenio, Vanessa Nadia, Cristofori, Fernanda, and Francavilla, Ruggiero
- Published
- 2022
- Full Text
- View/download PDF
29. Long-term outcomes of Heller's myotomy and balloon dilatation in childhood achalasia.
- Author
-
Thapar, Nikhil, Saliakellis, Efstratios, Cristofori, Fernanda, Lindley, Keith, Borrelli, Osvaldo, Roebuck, Derek, Cross, Kate, Kiely, Edward, and Curry, Joseph
- Subjects
ESOPHAGEAL achalasia ,ESOPHAGEAL motility disorders ,DEGLUTITION disorders in children ,JUVENILE diseases ,LAPAROSCOPIC surgery ,RANDOMIZED controlled trials ,FUNDOPLICATION ,THERAPEUTICS - Abstract
Achalasia is a rare esophageal motility disorder: its optimal treatment in children is still a matter of debate. Records of children treated for achalasia, over an 18-year period, were reviewed.Forty-eight children (median age at diagnosis 10 years; range 3-17 years) were identified. Twenty-eight patients were initially treated with Heller's myotomy (HM) and 20 with balloon dilatation (BD). At last follow-up (median 3 years; range 1-5.5 years), 43.8% (21/48) of children were symptom free. The number of asymptomatic children was significantly higher among those treated initially with HM compared to BD (HM 15/28, 53.6% BD 6/20, 30%, p < 0.05). All children who underwent BD required HM due to symptom recurrence. The median (range) total number of procedures was significantly higher in the BD group (BD 3 (1-7); HM 1 (1-5); p < 0.05) with a shorter time to the second intervention (BD 14 months, 95%CI 4-24; HM 58 months, 95%CI 38-79; p < 0.05). Of 108 procedures, esophageal perforation occurred in two children after HM (two out of 48 HM procedures in total, 4%) and one child after BD (1/60, 1.7%).
Conclusion: Less than half of children with achalasia are symptom free after initial treatment with either BD or HM. HM, however, when performed as first procedure, provided longer symptom-free period and reduced need for subsequent intervention. What is Known: • Balloon dilatation (BD) and Heller's myotomy (HM) are safe and effective treatment options for achalasia. • Controversy, however, exists regarding the most effective initial therapeutic approach. What is New: • HM with or without fundoplication may represent the initial therapeutic approach of choice. • Initial BD may negatively affect the outcome of a subsequent HM. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
30. Diagnosis of Non-Celiac Gluten Sensitivity (NCGS): The Salerno Experts' Criteria.
- Author
-
Catassi, Carlo, Elli, Luca, Bonaz, Bruno, Bouma, Gerd, Carroccio, Antonio, Castillejo, Gemma, Cellier, Christophe, Cristofori, Fernanda, de Magistris, Laura, Dolinsek, Jernej, Dieterich, Walburga, Francavilla, Ruggiero, Hadjivassiliou, Marios, Holtmeier, Wolfgang, Körner, Ute, Leffler, Dan A., Lundin, Knut E. A., Mazzarella, Giuseppe, Mulder, Chris J., and Pellegrini, Nicoletta
- Published
- 2015
- Full Text
- View/download PDF
31. Clinical Relevance of Esophageal Baseline Impedance Measurement: Just an Innocent Bystander.
- Author
-
Tambucci, Renato, Thapar, Nikhil, Saliakellis, Efstratios, Pescarin, Matilde, Quitadamo, Paolo, Cristofori, Fernanda, Lindley, Keith J., and Borrelli, Osvaldo
- Published
- 2015
- Full Text
- View/download PDF
32. Increased prevalence of celiac disease among pediatric patients with irritable bowel syndrome: a 6-year prospective cohort study.
- Author
-
Cristofori, Fernanda, Fontana, Claudia, Magistà, Annamaria, Capriati, Teresa, Indrio, Flavia, Castellaneta, Stefania, Cavallo, Luciano, and Francavilla, Ruggiero
- Published
- 2014
- Full Text
- View/download PDF
33. Celiac Disease and Overweight in Children: An Update.
- Author
-
Diamanti, Antonella, Capriati, Teresa, Basso, Maria Sole, Panetta, Fabio, Laurora, Vincenzo Maria Di Ciommo, Bellucci, Francesca, Cristofori, Fernanda, and Francavilla, Ruggiero
- Published
- 2014
- Full Text
- View/download PDF
34. Alterations of the Intestinal Permeability are Reflected by Changes in the Urine Metabolome of Young Autistic Children: Preliminary Results.
- Author
-
Piras, Cristina, Mussap, Michele, Noto, Antonio, De Giacomo, Andrea, Cristofori, Fernanda, Spada, Martina, Fanos, Vassilios, Atzori, Luigi, and Francavilla, Ruggiero
- Subjects
AUTISTIC children ,PROTON magnetic resonance ,PERMEABILITY ,NUCLEAR magnetic resonance ,INTESTINES ,URINE - Abstract
Several metabolomics-based studies have provided evidence that autistic subjects might share metabolic abnormalities with gut microbiota dysbiosis and alterations in gut mucosal permeability. Our aims were to explore the most relevant metabolic perturbations in a group of autistic children, compared with their healthy siblings, and to investigate whether the increased intestinal permeability may be mirrored by specific metabolic perturbations. We enrolled 13 autistic children and 14 unaffected siblings aged 2–12 years; the evaluation of the intestinal permeability was estimated by the lactulose:mannitol test. The urine metabolome was investigated by proton nuclear magnetic resonance (1H-NMR) spectroscopy. The lactulose:mannitol test unveiled two autistic children with altered intestinal permeability. Nine metabolites significantly discriminated the urine metabolome of autistic children from that of their unaffected siblings; however, in the autistic children with increased permeability, four additional metabolites—namely, fucose, phenylacetylglycine, nicotinurate, and 1-methyl-nicotinamide, strongly discriminated their urine metabolome from that of the remaining autistic children. Our preliminary data suggest the presence of a specific urine metabolic profile associated with the increase in intestinal permeability. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
35. Non-Celiac Gluten Sensitivity: The New Frontier of Gluten Related Disorders.
- Author
-
Catassi, Carlo, Bai, Julio C., Bonaz, Bruno, Bouma, Gerd, Calabrò, Antonio, Carroccio, Antonio, Castillejo, Gemma, Ciacci, Carolina, Cristofori, Fernanda, Dolinsek, Jernej, Francavilla, Ruggiero, Elli, Luca, Green, Peter, Holtmeier, Wolfgang, Koehler, Peter, Koletzko, Sibylle, Meinhold, Christof, Sanders, David, Schumann, Michael, and Schuppan, Detlef
- Published
- 2013
- Full Text
- View/download PDF
36. Esophageal Eosinophilia and Eosinophilic Esophagitis in Celiac Children: A Ten Year Prospective Observational Study.
- Author
-
Cristofori, Fernanda, D'Abramo, Fulvio Salvatore, Rutigliano, Vincenzo, Dargenio, Vanessa Nadia, Castellaneta, Stefania, Piscitelli, Domenico, De Benedittis, Davide, Indrio, Flavia, Raguseo, Lidia Celeste, Barone, Michele, and Francavilla, Ruggiero
- Abstract
The association between eosinophilic esophagitis and celiac disease is still controversial and its prevalence is highly variable. We aimed to investigate the prevalence of esophageal eosinophilia and eosinophilic esophagitis in a large group of children with celiac disease, prospectively followed over 11 years. Methods: Prospective observational study performed between 2008 and 2019. Celiac disease diagnosis was based on ESPGHAN criteria. At least four esophageal biopsies were sampled in patients who underwent endoscopy. The presence of at least 15 eosinophils/HPF on esophageal biopsies was considered suggestive of esophageal eosinophilia; at the same time, eosinophilic esophagitis was diagnosed according to the International Consensus Diagnostic Criteria for Eosinophilic Esophagitis. Results: A total of 465 children (M 42% mean age 7.1 years (range: 1–16)) were diagnosed with celiac disease. Three hundred and seventy patients underwent endoscopy, and esophageal biopsies were available in 313. The prevalence of esophageal eosinophilia in children with celiac disease was 1.6% (95% CI: 0.54–2.9%). Only one child was diagnosed as eosinophilic esophagitis; we calculated a prevalence of 0.3% (95% CI: 0.2–0.5%). The odds ratio for an association between eosinophilic esophagitis and celiac disease was at least 6.5 times higher (95% CI: 0.89–47.7%; p = 0.06) than in the general population. Conclusion: The finding of an increased number of eosinophils (>15/HPF) in celiac patients does not have a clinical implication or warrant intervention, and therefore we do not recommend routine esophageal biopsies unless clinically indicated. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
37. The Role of Helicobacter pylori Infection in Coronavirus Disease 2019, Cause or Coincidence?
- Author
-
Papagni, Maria Elena, Brindicci, Viviana Fara, Cristofori, Fernanda, and Francavilla, Ruggiero
- Published
- 2021
- Full Text
- View/download PDF
38. Selection of Gut-Resistant Bacteria and Construction of Microbial Consortia for Improving Gluten Digestion under Simulated Gastrointestinal Conditions.
- Author
-
De Angelis, Maria, Siragusa, Sonya, Vacca, Mirco, Di Cagno, Raffaella, Cristofori, Fernanda, Schwarm, Michael, Pelzer, Stefan, Flügel, Monika, Speckmann, Bodo, Francavilla, Ruggiero, Gobbetti, Marco, and Paolo, Usai-Satta
- Abstract
This work aimed to define the microbial consortia that are able to digest gluten into non-toxic and non-immunogenic peptides in the human gastrointestinal tract. Methods: 131 out of 504 tested Bacillus and lactic acid bacteria, specifically Bacillus (64), lactobacilli (63), Pediococcus (1), and Weissella (3), showed strong gastrointestinal resistance and were selected for their PepN, PepI, PepX, PepO, and PepP activities toward synthetic substrates. Based on multivariate analysis, 24 strains were clearly distinct from the other tested strains based on having the highest enzymatic activities. As estimated by RP-HPLC and nano-ESI–MS/MS, 6 cytoplasmic extracts out of 24 selected strains showed the ability to hydrolyze immunogenic epitopes, specifically 57–68 of α9-gliadin, 62–75 of A-gliadin, 134–153 of γ-gliadin, and 57–89 (33-mer) of α2-gliadin. Live and lysed cells of selected strains were combined into different microbial consortia for hydrolyzing gluten under gastrointestinal conditions. Commercial proteolytic enzymes (Aspergillusoryzae E1, Aspergillusniger E2, Bacillussubtilis Veron HPP, and Veron PS proteases) were also added to each microbial consortium. Consortium activity was evaluated by ELISA tests, RP-HPLC-nano-ESI–MS/MS, and duodenal explants from celiac disease patients. Results: two microbial consortia (Consortium 4: Lactiplantibacillus (Lp.) plantarum DSM33363 and DSM33364, Lacticaseibacillus (Lc.) paracasei DSM33373, Bacillussubtilis DSM33298, and Bacilluspumilus DSM33301; and Consortium 16: Lp. plantarum DSM33363 and DSM33364, Lc. paracasei DSM33373, Limosilactobacillusreuteri DSM33374, Bacillusmegaterium DSM33300, B.pumilus DSM33297 and DSM33355), containing commercial enzymes, were able to hydrolyze gluten to non-toxic and non-immunogenic peptides under gastrointestinal conditions. Conclusions: the results of this study provide evidence that selected microbial consortia could potentially improve the digestion of gluten in gluten-sensitive patients by hydrolyzing the immunogenic peptides during gastrointestinal digestion. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
39. Iodine Absorption in Celiac Children: A Longitudinal Pilot Study.
- Author
-
Delvecchio, Maurizio, Bizzoco, Francesca, Lapolla, Rosa, Gentile, Antonia, Carrozza, Cinzia, Barone, Michele, Simonetti, Simonetta, Giordano, Paola, Dargenio, Vanessa Nadia, Cristofori, Fernanda, Francavilla, Ruggiero, and Verma, Anil K.
- Abstract
Background: non-autoimmune thyroid disorder is a common finding in celiac patients, more frequent than in the general population. An impairment of iodine absorption has been hypothesized, but it has never been investigated so far. We aimed to evaluate the iodine absorption in children and adolescents with newly diagnosed celiac disease. Methods: 36 consecutive celiac patients (age 7.4 years, range 2.4–14.5 years) before starting a gluten-free diet (GFD) were enrolled. We assayed the urinary iodine concentration (UIC) in a 24-h urine sample, at baseline (T0) after 3 (T1) and 12 months (T2) of GFD. Results: UIC at T0 was 64 μg/L (IQR 45–93.25 μg/L) with an iodine deficiency rate of 77.8%. UIC was not different according to histological damage, clinical presentation (typical vs atypical); we found no correlation with the thyroid function tests and auxological parameters. UIC was not statistically different at T1 (76 μg/L) and T2 (89 μg/L) vs T0. UIC at T2 was similar between patients with positive and negative anti-transglutaminase antibodies at T2. No patients presented overt hypothyroidism during the study. Conclusions: We found that iodine absorption in celiac children is impaired compared to the general population; it increases slightly, but not significantly, during the GFD. We should regularly reinforce the need for a proper iodine intake in celiac disease patients to reduce iodine deficiency risk. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
40. Evaluation of Non-Celiac Gluten Sensitivity in Patients with Previous Diagnosis of Irritable Bowel Syndrome: A Randomized Double-Blind Placebo-Controlled Crossover Trial.
- Author
-
Barone, Michele, Gemello, Eugenio, Viggiani, Maria Teresa, Cristofori, Fernanda, Renna, Caterina, Iannone, Andrea, Di Leo, Alfredo, and Francavilla, Ruggiero
- Abstract
Background. To date, there is no reliable marker for the diagnosis of non-celiac gluten sensitivity (NCGS), which benefits from a gluten-free diet (GFD). This condition is characterized by functional gastrointestinal symptoms similar to those occurring in the course of irritable bowel syndrome (IBS). However, IBS has a higher prevalence, and often benefits from the administration of a low fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) diet. The overlap of symptoms between these two pathologies has led to an overestimation of self-made diagnosis NCGS. Aims. To better identify NCGS in subjects with a previous diagnosis of IBS. Methods. All subjects received a low FODMAP diet that was also gluten-free (low FODMAP-GFD), and those presenting an improvement of symptoms were exposed to gluten or placebo (double-blind challenge with wash-out and crossover). The response to dietary treatments was evaluated by visual analogue scale (VAS). Results. Of 30 patients (23 women, seven men, aged 42.2 ± 12.5 years, body mass index (BMI) 24.7 ± 4.1 kg/m
2 ), 26 benefited from the administration of low FODMAP-GFD and were exposed to the gluten/placebo challenge. After the challenge, using an increase of visual analogue scale VAS (Δ-VAS) ≥30%, 46.1% of the patients were NCGS+. However, this percentage became only 19.2% using a different method (mean ∆-VAS score plus two standard deviations). Conclusions. FODMAP intolerance could hide the response to a challenge test with gluten for the identification of NCGS in IBS patients. A low FODMAP-GFD followed by gluten/placebo challenge is able to identify patients with NCGS better. ClinicalTrials.gov registration number NCT04017585. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
41. New Protocol for Production of Reduced-Gluten Wheat Bread and Pasta and Clinical Effect in Patients with Irritable Bowel Syndrome: A randomised, Double-Blind, Cross-Over Study.
- Author
-
Calasso, Maria, Francavilla, Ruggiero, Cristofori, Fernanda, De Angelis, Maria, and Gobbetti, Marco
- Abstract
It has been suggested that sourdough fermented products have beneficial health effects. Fungal proteases and selected sourdough lactic acid bacteria were used to produce wheat bread and pasta with a reduced-gluten content (<50% of traditional products). Fermentable oligo-, di- and mono- saccharides and polyols and amylase/trypsin inhibitors were also evaluated. The sensorial features of new products were similar to traditional ones. The efficacy of these new products in reducing the severity of symptoms in Irritable Bowel Syndrome (IBS) patients were compared to traditional bread and pasta using a randomized, crossover-controlled trial. While on a strict gluten-free diet, patients were randomized to consume a reduced- or normal-gluten diet for 2weeks; then, patients from both arms started the wash-out period of one week, and subsequently started the final 2-week period on a normal or reduced-gluten diet. Compared to normal-gluten content, the administration of a reduced-gluten content diet resulted in a decrease of the Visual Analogue Scale score (p = 0.042), while no differences were found in the IBS-Severity Score, Hospital Anxiety and Depression Scale, and IBS-Quality of Life. Data herein reported are novel encouraging findings that should spur a new avenue of research aiming to develop products specifically designed for IBS patients. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
42. Probiotics in Celiac Disease.
- Author
-
Cristofori, Fernanda, Indrio, Flavia, Miniello, Vito Leonardo, De Angelis, Maria, and Francavilla, Ruggiero
- Abstract
Recently, the interest in the human microbiome and its interplay with the host has exploded and provided new insights on its role in conferring host protection and regulating host physiology, including the correct development of immunity. However, in the presence of microbial imbalance and particular genetic settings, the microbiome may contribute to the dysfunction of host metabolism and physiology, leading to pathogenesis and/or the progression of several diseases. Celiac disease (CD) is a chronic autoimmune enteropathy triggered by dietary gluten exposure in genetically predisposed individuals. Despite ascertaining that gluten is the trigger in CD, evidence has indicated that intestinal microbiota is somehow involved in the pathogenesis, progression, and clinical presentation of CD. Indeed, several studies have reported imbalances in the intestinal microbiota of patients with CD that are mainly characterized by an increased abundance of Bacteroides spp. and a decrease in Bifidobacterium spp. The evidence that some of these microbial imbalances still persist in spite of a strict gluten-free diet and that celiac patients suffering from persistent gastrointestinal symptoms have a desert gut microbiota composition further support its close link with CD. All of this evidence gives rise to the hypothesis that probiotics might play a role in this condition. In this review, we describe the recent scientific evidences linking the gut microbiota in CD, starting from the possible role of microbes in CD pathogenesis, the attempt to define a microbial signature of disease, the effect of a gluten-free diet and host genetic assets regarding microbial composition to end in the exploration of the proof of concept of probiotic use in animal models to the most recent clinical application of selected probiotic strains. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
43. Indications and Recommendations by Societies and Institutions for the Use of Probiotics and Prebiotics in Paediatric Functional Intestinal Disorders.
- Author
-
Francavilla, Ruggiero, Cristofori, Fernanda, and Indrio, Flavia
- Published
- 2016
44. Whoever is Free from “Placebo Sensitivity”, Cast the First Stone!
- Author
-
Francavilla, Ruggiero, Cristofori, Fernanda, De Benedittis, Davide, and Indrio, Flavia
- Published
- 2018
- Full Text
- View/download PDF
45. Double dose of bisacodyl increases the diagnostic yield of colonic manometry.
- Author
-
Pescarin, Matilde, Thapar, Nikhil, Saliakellis, Efstratios, Tambucci, Renato, Giorgio, Valentina, Cristofori, Fernanda, Lindley, Keith, and Borrelli, Osvaldo
- Published
- 2014
- Full Text
- View/download PDF
46. Clinical relevance of esophageal baseline impedance measurement.
- Author
-
Tambucci, Renato, Thapar, Nikhil, Saliakellis, Efstratios, Pescarin, Matilde, Quitadamo, Paolo, Cristofori, Fernanda, Lindley, Keith J., and Borrelli, Osvaldo
- Published
- 2014
- Full Text
- View/download PDF
47. Prevalence of FGIDs is increased in CD patient despite strict GFD.
- Author
-
Cristofori, Fernanda, Moretti, Roberta, Cassano, Gilda, Silecchia, Valeria, Indrio, Flavia, Castellaneta, Stefania, Lorusso, Giusy, Cavallo, Luciano, and Francavilla, Ruggiero
- Published
- 2014
- Full Text
- View/download PDF
48. Fecal Microbiota and Metabolome of Children with Autism and Pervasive Developmental Disorder Not Otherwise Specified.
- Author
-
De Angelis, Maria, Piccolo, Maria, Vannini, Lucia, Siragusa, Sonya, De Giacomo, Andrea, Serrazzanetti, Diana Isabella, Cristofori, Fernanda, Guerzoni, Maria Elisabetta, Gobbetti, Marco, and Francavilla, Ruggiero
- Subjects
TREATMENT of autism in children ,FECAL microbiota transplantation ,METABOLOMICS ,PERVASIVE child development disorders ,RECOMBINANT DNA ,RIBOSOMAL RNA ,AUTISM ,PREVENTION - Abstract
This study aimed at investigating the fecal microbiota and metabolome of children with Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) and autism (AD) in comparison to healthy children (HC). Bacterial tag-encoded FLX-titanium amplicon pyrosequencing (bTEFAP) of the 16S rDNA and 16S rRNA analyses were carried out to determine total bacteria (16S rDNA) and metabolically active bacteria (16S rRNA), respectively. The main bacterial phyla (Firmicutes, Bacteroidetes, Fusobacteria and Verrucomicrobia) significantly (P<0.05) changed among the three groups of children. As estimated by rarefaction, Chao and Shannon diversity index, the highest microbial diversity was found in AD children. Based on 16S-rRNA and culture-dependent data, Faecalibacterium and Ruminococcus were present at the highest level in fecal samples of PDD-NOS and HC children. Caloramator, Sarcina and Clostridium genera were the highest in AD children. Compared to HC, the composition of Lachnospiraceae family also differed in PDD-NOS and, especially, AD children. Except for Eubacterium siraeum, the lowest level of Eubacteriaceae was found on fecal samples of AD children. The level of Bacteroidetes genera and some Alistipes and Akkermansia species were almost the highest in PDD-NOS or AD children as well as almost all the identified Sutterellaceae and Enterobacteriaceae were the highest in AD. Compared to HC children, Bifidobacterium species decreased in AD. As shown by Canonical Discriminant Analysis of Principal Coordinates, the levels of free amino acids and volatile organic compounds of fecal samples were markedly affected in PDD-NOS and, especially, AD children. If the gut microbiota differences among AD and PDD-NOS and HC children are one of the concomitant causes or the consequence of autism, they may have implications regarding specific diagnostic test, and/or for treatment and prevention. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
49. Gut microbiota biomodulators, when the stork comes by the scalpel.
- Author
-
Miniello, Vito Leonardo, Colasanto, Angela, Cristofori, Fernanda, Diaferio, Lucia, Ficele, Laura, Lieggi, Maria Serena, Santoiemma, Valentina, and Francavilla, Ruggiero
- Subjects
- *
GUT microbiome , *IMMUNOMODULATORS , *STORKS , *HOMEOSTASIS , *HEALTH impact assessment - Abstract
The microbial communities that reside in the human gut (microbiota) and their impact on human health and disease are nowadays one of the most exciting new areas of research. A well-balanced microbial intestinal colonization in early postnatal life is necessary for the development of appropriate innate and adaptive immune responses and to establish immune homeostasis later in life. Although the composition and functional characteristics of a ‘healthy’ gut microbiota remain to be elucidated, perturbations in the microbial colonization of an infant's gastrointestinal tract have been associated with an increased risk of short- and long-term immunologically mediated diseases. Emerging evidence suggests that gut microbiota biomodulators, such as probiotics, prebiotics, synbiotics, and postbiotics may support disease prevention in infants who tend to have a delayed and/or aberrant initial colonization with reduced microbiota diversity (delivery by caesarean section, premature delivery, and excessive use of perinatal antibiotics). Under these dysbiosis conditions probiotics could act as ‘surrogate’ colonizers to prevent immune-mediated diseases. This review focuses on the influence of delivery mode on the colonization of the infant gastro-intestinal tract. In particular, it examines the manipulation of the gut microbiota composition through the use of gut microbiota biomodulators, in the management of aberrant initial gut colonization and subsequent consequences for the health of the offspring. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.